IGNITE Immunotherapy
Alameda
About IGNITE Immunotherapy
IGNITE Immunotherapy is working to unlock the full potential of cancer immunotherapy. Their optimized intravenous oncolytic cancer vaccines are designed to complement approved immune checkpoint inhibitors by igniting an immune response to patients’ cancers. Their purpose is to cure cancer patients through combination immunotherapy with their intravenous oncolytic vaccines.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: igniteimmunotherapy.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/ignite-immunotherapy-2443156 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.